© 2017 Chart Industries, Inc. Confidential and Proprietary
Chart Industries, Inc.
Investor Presentation
March 2017
Exhibit 99.1
© 2017 Chart Industries, Inc. Confidential and Proprietary 2
Disclosure
Forward-Looking Statements: This presentation includes “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. The use of words such as “may,” “might,” “should,” “will,” “expect,” “plan,” “anticipate,” “believe,”
“estimate,” “project,” “forecast,” “outlook,” “intend,” “future,” “potential” or “continue”, and other similar expressions are intended to
identify forward-looking statements. All of these forward-looking statements are based on estimates and assumptions by our
management as of the date of this presentation that, although we believe to be reasonable, are inherently uncertain. Forward-looking
statements involve risks and uncertainties that could cause the Company’s actual results or circumstances to differ materially from
those expressed or implied by forward-looking statements. These risks and uncertainties include, among others, the following: the
cyclicality of the markets that the Company serves and the vulnerability of those markets to economic downturns; a delay, significant
reduction in or loss of purchases by large customers; fluctuations in energy prices; our ability to control our costs and successfully
manage our operations; our ability to achieve expected savings and productivity improvements from the consolidation of certain of our
facilities and operations; a delay in the anticipated timing of LNG infrastructure build out or a delay or failure to receive orders; the
potential for negative developments in the natural gas industry related to hydraulic fracturing; competition; potential future impairment
of the Company’s significant goodwill and other intangibles; changes in government energy policy or the failure of expected changes
in policy to materialize; variability in operating results associated with unanticipated increases in warranty returns of Company
products; the modification or cancellation of orders in our backlog; loss of key employees; challenges and uncertainties associated
with efforts to acquire and integrate product lines or businesses; economic downturns and deteriorating financial conditions; our ability
to manage our fixed-price contract exposure; our reliance on key suppliers and potential supplier failures or defects; fluctuations or
adjustments in the Company’s effective tax rate; changes in government healthcare regulations and reimbursement policies; litigation
and disputes involving the Company, including product liability, contract, warranty, intellectual property, employment and
environmental claims; fluctuations in foreign currency exchange and interest rates; general economic, political, business and market
risks associated with the Company's international operations and transactions; technological security threats; financial distress of third
parties; our ability to protect our intellectual property; the regulation of our products by the U.S. Food & Drug Administration and other
governmental authorities; the pricing and availability of raw materials; the cost of compliance with environmental, health and safety
laws; claims that our products or processes infringe intellectual property rights of others; additional liabilities related to taxes;
deterioration of employee or labor relations; increased governmental regulation; risks associated with our indebtedness, leverage and
liquidity; and volatility and fluctuations in the price of the Company’s stock. For a discussion of these and additional risks that could
cause actual results to differ from those described in the forward-looking statements, see disclosure under Item 1A. “Risk Factors” in
the Company’s most recent Annual Report on Form 10-K and other recent filings with the Securities and Exchange Commission,
which should be reviewed carefully. Please consider the Company’s forward-looking statements in light of these risks. Any forward-
looking statement speaks only as of its date. We undertake no obligation to publicly update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise, except as required by law.
© 2017 Chart Industries, Inc. Confidential and Proprietary 3
#1 or #2
in all primary
industries served
Diversified Industry Leader
$171M
FY 2016
Leading Industry
Positions
Robust Operating
Cash Flows
Significant
Liquidity
$450M
Revolving Credit
Facility
© 2017 Chart Industries, Inc. Confidential and Proprietary 4
Driven By Technology
Chart is a recognized global brand for the design and manufacture of highly engineered
cryogenic equipment used from beginning to end in the liquid gas supply chain.
You may never use the products we make, but everyone uses the products we make possible.
Innovation
Experience
Performance We fulfill expectations with proven solutions to
meet customer needs.
Customers rely on our knowledge and products
because we are experts in our field.
Core competencies in cryogenics, gas processing
and low temperature storage.
© 2017 Chart Industries, Inc. Confidential and Proprietary 5
Unique Business Portfolio
Distribution & Storage
(D&S)
BioMedical
Energy & Chemicals
(E&C)
Energy
Industrial
Healthcare
Life Sciences
In
d
u
st
rie
s
S
e
rv
e
d
© 2017 Chart Industries, Inc. Confidential and Proprietary 6
Corporate Energy & Chemicals Distribution & Storage BioMedical
North America
Strategically Located Operations
Geographic diversification providing competitive advantage
Europe Asia - Pacific
© 2017 Chart Industries, Inc. Confidential and Proprietary 7
Mission Critical Equipment Provider
Supplier of Brazed Aluminum Heat Exchangers (BAHX), Air Cooled Heat
Exchangers (ACHX) and Cold Boxes
Provider of integrated systems and aftermarket services for gas processing,
LNG and petrochemical applications
Technology leader for over 50 years
Highly engineered equipment and systems used in the separation, liquefaction and purification of
hydrocarbon and industrial gases for natural gas processing, LNG and industrial gas applications
Energy & Chemicals
© 2017 Chart Industries, Inc. Confidential and Proprietary 8
$100M
Backlog at 12/31/16
51%
16%
23%
10%
7%
25%
68%
Industry
Serving Energy Markets Globally
18%
of Total Chart Sales
29%
Gross Margin
Region
LNG
Industrial
Gas
Natural Gas
Processing/
Petrochemical
United
States
Asia
ROW
Energy & Chemicals
E&C FY 2016 Sales of $154.2M FY 2016 Highlights
Middle
East
© 2017 Chart Industries, Inc. Confidential and Proprietary 9
Leading Cryogenic Equipment Provider
Designer, manufacturer and service provider of cryogenic solutions for the storage and
delivery of cryogenic liquids used in industrial gas and LNG applications
Complete portfolio of cryogenic distribution and storage equipment
Leading innovator in cryogenic packaged gas and MicroBulk systems
Over 20 years of experience in LNG applications
Distribution & Storage
© 2017 Chart Industries, Inc. Confidential and Proprietary 10
Diversified Product Portfolio
58%
of Total Chart Sales
$218M
Backlog at 12/31/16
59%
22%
7%
5%
7%
53%
18%
22%
7%
D&S FY 2016 Sales of $497.1M
26%
Gross Margin
LNG
Manufacturing/
Fabrication
Asia
Europe
ROW
United
States
Industry Region
Food/
Beverage
Electronics
Healthcare
FY 2016 Highlights
Distribution & Storage
© 2017 Chart Industries, Inc. Confidential and Proprietary 11
Innovative Solution Provider
Healthcare, life science and environmental product lines built around our core
competencies in cryogenics and gas processing, but with a focus on the users of
cryogenic liquids and gases
End to end provider of respiratory therapy equipment
Set the standard for storage of biological materials at low temperatures
Reliable, high quality solutions for environmental market applications
BioMedical
© 2017 Chart Industries, Inc. Confidential and Proprietary 12
Serving Growing Global End Markets
24%
of Total Chart Sales
57%
34%
9%
41%
17%
34%
8%
BioMed FY 2016 Sales of $207.8M
$25M
Backlog at 12/31/16
44%
Gross Margin
Asia
Europe
ROW
United
States
Environmental
Life
Sciences
Healthcare
Industry Region
FY 2016 Highlights
BioMedical
© 2017 Chart Industries, Inc. Confidential and Proprietary 13
Current Challenges
Continued weak energy market conditions
Delayed investments in upstream equipment
How we are addressing challenges
Aggressive cost reductions in down segments with global
headcount down 27% from the end of 2014
Continue facility consolidation efforts to create further operating
efficiencies and leverage support functions across the business
Focus on operational excellence and strategic goals for long-
term growth when market returns
Invest in additional capacity at our brazed aluminum heat
exchanger facility
© 2017 Chart Industries, Inc. Confidential and Proprietary 14
Dynamic Global Strategy
Maximize LNG Opportunity
Expand Industrial Gas Offerings
Innovation Through Technology
Pursue New Organic and Inorganic
Growth Opportunities
© 2017 Chart Industries, Inc. Confidential and Proprietary 15
Expand Industrial Gas Offerings
Global Strategy
Focus on high pressure heat exchangers
Best-in-Industry delivery
Expand long-term customer relationships through
Lifecycle service offerings
Target developing areas where growth potential
is greater than regional GDP
New product offerings
Distribution & Storage
Energy & Chemicals
© 2017 Chart Industries, Inc. Confidential and Proprietary 16
Standardized small and midscale LNG plants
Expand our integrated system and aftermarket
offerings
Capture floating liquefaction (FLNG) opportunities
Maximize LNG Opportunity
Target R&D efforts on developing markets
Customer partnerships to develop joint solutions
Enhance engineering and project management
capabilities to capture more systems contracts
Distribution & Storage
Energy & Chemicals
Global Strategy
© 2017 Chart Industries, Inc. Confidential and Proprietary 17
Innovation Through Technology
Eclipse 5®
Portable Oxygen
Concentrator
Nomad Mobile
Storage and
Delivery System
New industrial products
Continued investment in LNG product offerings
Accelerated new product introduction
Improve portable oxygen concentrators
IPSMR® liquefaction technology
Continuous BAHX innovation and
investment
BioMedical
Distribution & Storage
Energy & Chemicals Process System
Global Strategy
© 2017 Chart Industries, Inc. Confidential and Proprietary 18
$282M
Cash at 12/31/2016
$450M
Revolving Credit
Facility
Well Positioned For Continued Growth
2.50x
Current Ratio*
Significant Liquidity Solid Balance Sheet
26%
Debt / Capital %**
** Total Debt (ST + LT Debt) / Total Capital (Common Equity + Noncontrolling Interests + Total Debt) as of 12/31/2016
* Total Current Assets / Total Current Liabilities as of 12/31/2016
Future Growth
© 2017 Chart Industries, Inc. Confidential and Proprietary 19
Why Invest In Chart?
Stable Industrial Gas
business
Growing BioMedical
opportunities
Long-term growth
opportunities through
build out of LNG
Selling to a wide range of
global industries
Well Diversified
Business
Proven Track Record
Investing for
Continued Growth
Strategic goals to
expand current platform
and increase profitability
Pursuing organic and
inorganic growth
opportunities
Market leadership
through quality and
innovation
Flexible cost structure to
accommodate cyclic
portions of the business
Strong cash flow
generation
Conclusion
© 2017 Chart Industries, Inc. Confidential and Proprietary
www.ChartIndustries.com
20